{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:30:06Z","timestamp":1784716206719,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jad.2015.11.002","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T16:50:35Z","timestamp":1448470235000},"page":"256-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium"],"prefix":"10.1016","volume":"191","author":[{"given":"Terence A.","family":"Ketter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shefali","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Dell\u2019Osso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po W.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2015.11.002_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jad.2008.01.017","article-title":"Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study","volume":"110","author":"Altamura","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.11.002_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10673221003747955","article-title":"Bipolar depression: overview and commentary","volume":"18","author":"Baldessarini","year":"2010","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.002_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jad.2014.02.046","article-title":"Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial","volume":"161","author":"Bobo","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.11.002_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jad.2009.10.023","article-title":"Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)","volume":"124","author":"Bond","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.11.002_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40345-014-0014-9","article-title":"Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study","volume":"2","author":"Bourin","year":"2014","journal-title":"Int. J. Bipolar. Disord."},{"key":"10.1016\/j.jad.2015.11.002_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v66n0116","article-title":"A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder","volume":"66","author":"Bowden","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.002_bib8","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.002_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hup.1095","article-title":"Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004","volume":"25","author":"Centorrino","year":"2010","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.11.002_bib10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jpsychires.2012.01.014","article-title":"Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population","volume":"46","author":"Choong","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2015.11.002_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1586\/14737175.2014.947965","article-title":"Lithium for bipolar disorder: a review of the recent literature","volume":"14","author":"Curran","year":"2014","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jad.2015.11.002_bib12","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.2165\/00003495-200565170-00008","article-title":"Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder","volume":"65","author":"Dando","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.jad.2015.11.002_bib13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/15622970903544638","article-title":"Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics","volume":"11","author":"Dikeos","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.002_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jad.2013.05.052","article-title":"Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trials","volume":"152\u2013154","author":"Friedman","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.11.002_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(09)61828-6","article-title":"Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial","volume":"375","author":"Geddes","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2015.11.002_bib16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: revised second edition\u2014recommendations from the British Association for Psychopharmacology","volume":"23","author":"Goodwin","year":"2009","journal-title":"J. Psychopharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.jad.2015.11.002_bib17","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1399-5618.2009.00707.x","article-title":"A critical appraisal of lithium\u2019s efficacy and effectiveness: the last 60 years","volume":"11","author":"Grof","year":"2009","journal-title":"Bipolar. Disord."},{"key":"10.1016\/j.jad.2015.11.002_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15622970902823202","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania","volume":"10","author":"Grunze","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.002_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/15622970903555881","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression","volume":"11","author":"Grunze","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.002_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/15622975.2013.770551","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder","volume":"14","author":"Grunze","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.002_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1745-0179-1-7","article-title":"Combination quetiapine therapy in the long-term treatment of patients with bipolar I disorder","volume":"1","author":"Hardoy","year":"2005","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"10.1016\/j.jad.2015.11.002_bib22","doi-asserted-by":"crossref","unstructured":"Hirschfeld,\u00a0R.M.A., 2007. Guideline Watch (November 2005): Practice Guideline for the Treatment of Patients With Bipolar Disorder, 2nd Edition. In:\u00a0Focus, vol. 5, pp.\u00a034-39.","DOI":"10.1176\/foc.5.1.34"},{"key":"10.1016\/j.jad.2015.11.002_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jad.2013.10.054","article-title":"Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000\u20132011","volume":"155","author":"Hooshmand","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.11.002_bib24","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.4088\/JCP.v69n1014","article-title":"International Consensus Group on the evidence-based pharmacologic treatment of bipolar I and II depression","volume":"69","author":"International Consensus Group","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.002_bib25","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1185\/030079906X148616","article-title":"Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice","volume":"22","author":"Ketter","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2015.11.002_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jad.2013.12.032","article-title":"Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression","volume":"157","author":"Kim","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.11.002_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/14737167.7.5.459","article-title":"Pharmacoeconomics of quetiapine for the management of acute mania in bipolar I disorder","volume":"7","author":"Klok","year":"2007","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"10.1016\/j.jad.2015.11.002_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/030079908X253933","article-title":"Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study","volume":"24","author":"Li","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2015.11.002_bib29","unstructured":"Lithium citrate tetrahydrate, 2013. Lithium Citrate Tetrahydrate (Summary of Product Characteristics), Rosemont Pharmaceuticals Ltd., Leeds, UK"},{"key":"10.1016\/j.jad.2015.11.002_bib30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4088\/JCP.08m04942gre","article-title":"A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II)","volume":"71","author":"McElroy","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.002_bib31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.euroneuro.2005.02.006","article-title":"Quetiapine or haloperidol as monotherapy for bipolar mania\u2014a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial","volume":"15","author":"McIntyre","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2015.11.002_bib32","unstructured":"National Collaborating Centre for Mental Health (UK), 2006. Bipolar disorder: the management of bipolar disorders in adults, children and adolescents, in primary and secondary care. NICE clinical Guidelines, No. 38. British Psychological Society. Available at: \u3008http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK55364\/\u3009 (accessed on 10.08.15)."},{"key":"10.1016\/j.jad.2015.11.002_bib34","series-title":"Bipolar CHOICE (Clinical Health Outcomes Initiative for Comparative Effectiveness)","author":"Nierenberg","year":"2014"},{"key":"10.1016\/j.jad.2015.11.002_bib35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/1740774513512184","article-title":"Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder","volume":"11","author":"Nierenberg","year":"2014","journal-title":"Clin. Trials"},{"key":"10.1016\/j.jad.2015.11.002_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bdi.12027","article-title":"The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144)","volume":"15","author":"Nolen","year":"2013","journal-title":"Bipolar. Disord."},{"key":"10.1016\/j.jad.2015.11.002_bib37","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1176\/appi.ajp.2013.13020185","article-title":"The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders","volume":"170","author":"Pacchiarotti","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.002_bib38","first-page":"92","article-title":"The diagnosis and treatment of bipolar disorder: recommendations from the current s3 guideline","volume":"110","author":"Pfennig","year":"2013","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.jad.2015.11.002_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1176\/appi.ps.201100092","article-title":"Trends in use of second-generation antipsychotics for treatment of bipolar disorder in the United States, 1998\u20132009","volume":"63","author":"Pillarella","year":"2012","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2015.11.002_bib40","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0149-2918(02)80081-9","article-title":"Open-label study of the effect of combination quetiapine\/lithium therapy on lithium pharmacokinetics and tolerability","volume":"24","author":"Potkin","year":"2002","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jad.2015.11.002_bib41","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1592\/phco.31.8.806","article-title":"Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders","volume":"31","author":"Prabhakar","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jad.2015.11.002_bib42","unstructured":"Quetiapine fumarate prescribing information (Seroquel), 2013. AstraZeneca Pharmaceuticals, Wilmington, DE."},{"key":"10.1016\/j.jad.2015.11.002_bib43","unstructured":"Quetiapine fumarate extended release prescribing information (Seroquel XR), 2013.\u00a0AstraZeneca Pharmaceuticals, Wilmington, DE."},{"key":"10.1016\/j.jad.2015.11.002_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","article-title":"Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study","volume":"6","author":"Sachs","year":"2004","journal-title":"Bipolar. Disord."},{"key":"10.1016\/j.jad.2015.11.002_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/11203840-000000000-00000","article-title":"Quetiapine: a review of its use in the management of bipolar depression","volume":"26","author":"Sanford","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2015.11.002_bib46","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0278-5846(03)00145-3","article-title":"Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate","volume":"27","author":"Sokolski","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.002_bib47","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1111\/j.1530-0277.2010.01270.x","article-title":"A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence","volume":"34","author":"Stedman","year":"2010","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.jad.2015.11.002_bib48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jad.2009.10.007","article-title":"Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression","volume":"121","author":"Suppes","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.11.002_bib49","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4088\/JCP.v66n0710","article-title":"The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder","volume":"66","author":"Suppes","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.002_bib50","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/YIC.0b013e3281c55f63","article-title":"Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network","volume":"22","author":"Suppes","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.11.002_bib51","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/da.22136","article-title":"Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials","volume":"30","author":"Suppes","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2015.11.002_bib52","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2008.08020189","article-title":"Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (trial 127)","volume":"166","author":"Suppes","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.002_bib53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/acps.12202","article-title":"Medication adherence in a comparative effectiveness trial for bipolar disorder","volume":"129","author":"Sylvia","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2015.11.002_bib54","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","article-title":"Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)","volume":"26","author":"Thase","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.11.002_bib55","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2008.06.001","article-title":"Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126)","volume":"109","author":"Vieta","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.11.002_bib56","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.4088\/JCP.11m06878","article-title":"Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (trial 144: a randomized controlled study)","volume":"72","author":"Weisler","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.002_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar. Disord."},{"key":"10.1016\/j.jad.2015.11.002_bib58","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/01.jcp.0000144887.66319.2f","article-title":"Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania","volume":"24","author":"Yatham","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.11.002_bib59","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/YIC.0b013e328080ca57","article-title":"A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania","volume":"22","author":"Yatham","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.11.002_bib501","doi-asserted-by":"crossref","unstructured":"Young, A.H., Calabrese, J.R., Gustafson, U., Berk, M., McElroy, S.L., Thase, M.E., Suppes, T., Earley, W., 2013. Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies. Int. J. Bipolar Discord. 1, 10","DOI":"10.1186\/2194-7511-1-10"},{"key":"10.1016\/j.jad.2015.11.002_bib60","doi-asserted-by":"crossref","unstructured":"Young, A.H., McElroy, S.L., Bauer, M., Philips, N., Chang, W., Olausson, B., Paulsson, B., Brecher, M., 2010. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I), J. Clin. Psychiatry 71, 150\u2013162","DOI":"10.4088\/JCP.08m04995gre"},{"key":"10.1016\/j.jad.2015.11.002_bib61","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/15622975.2012.665177","article-title":"A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder","volume":"15","author":"Young","year":"2014","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.002_bib62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jad.2006.08.009","article-title":"Atypical antipsychotics related metabolic syndrome in bipolar patients","volume":"98","author":"Yumru","year":"2007","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715307722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715307722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T13:12:07Z","timestamp":1668604327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032715307722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":61,"alternative-id":["S0165032715307722"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2015.11.002","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2015.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}